Role of MALAT1 in gynecological cancers: Pathologic and therapeutic aspects (Review)
- Authors:
- Feng-Hua Qiao
- Min Tu
- Hong-Yan Liu
-
Affiliations: Department of Gynecology, Second People's Hospital of Jingmen, Jingmen, Hubei 448000, P.R. China, Department of Orthopedics, Second People's Hospital of Jingmen, Jingmen, Hubei 448000, P.R. China, Department of Gynecology, Maternal and Child Health Hospital of Jingmen, Jingmen, Hubei 448000, P.R. China - Published online on: February 25, 2021 https://doi.org/10.3892/ol.2021.12594
- Article Number: 333
This article is mentioned in:
Abstract
 |
|
Jeong HM, Kwon MJ and Shin YK: Overexpression of cancer-associated genes via epigenetic derepression mechanisms in gynecologic cancer. Front Oncol. 4:122014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou XM, Zhang H and Han X: Role of epithelial to mesenchymal transition proteins in gynecological cancers: Pathological and therapeutic perspectives. Tumour Biol. 35:9523–9530. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Liu DT: EMMPRIN in gynecologic cancers: Pathologic and therapeutic aspects. Tumour Biol. 36:4883–4888. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gusberg SB: The gynecologist and breast cancer. Isr J Med Sci. 17:843–846. 1981.PubMed/NCBI | |
|
Imani S, Hosseinifard H, Cheng J, Wei C and Fu J: Prognostic value of EMT-inducing transcription factors (EMT-TFs) in metastatic breast cancer: A systematic review and meta-analysis. Sci Rep. 6:285872016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu S, Wang H, Zhang L, Tang C, Jones L, Ye H, Ban L, Wang A, Liu Z, Lou F, et al: Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing. Hum Genomics. 9:22015. View Article : Google Scholar : PubMed/NCBI | |
|
Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR and Gray S: Environmental pollutants, diet, physical activity, body size, and breast cancer: Where do we stand in research to identify opportunities for prevention? Cancer. 109 (12 Suppl):S2627–S2634. 2007. View Article : Google Scholar | |
|
Rezaeian M, Sharifirad G, Mostafavi F, Moodi M and Abbasi MH: The effects of breast cancer educational intervention on knowledge and health beliefs of women 40 years and older, Isfahan, Iran. J Educ Health Promot. 3:432014.PubMed/NCBI | |
|
Tania M, Khan MA and Song Y: Association of lipid metabolism with ovarian cancer. Curr Oncol. 17:6–11. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Goff BA: Ovarian cancer: Screening and early detection. Obstet Gynecol Clin North Am. 39:183–194. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Piek JM, van Diest PJ and Verheijen RH: Ovarian carcinogenesis: An alternative hypothesis. Adv Exp Med Biol. 622:79–87. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Vargas-Hernández VM, Moreno-Eutimio MA, Acosta-Altamirano G and Vargas-Aguilar VM: Management of recurrent epithelial ovarian cancer. Gland Surg. 3:198–202. 2014.PubMed/NCBI | |
|
Canavan TP and Doshi NR: Cervical cancer. Am Fam Physician. 61:1369–1376. 2000.PubMed/NCBI | |
|
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Muñoz N, Castellsagué X, de González AB and Gissmann L: Chapter 1: HPV in the etiology of human cancer. Vaccine. 24 (Suppl 3):S3/1–10. 2006. View Article : Google Scholar | |
|
Pessoa JN, Freitas AC, Guimaraes RA, Lima J, Dos Reis HL and Filho AC: Endometrial assessment: When is it necessary? J Clin Med Res. 6:21–25. 2014.PubMed/NCBI | |
|
Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C and Sessa C; ESMO Guidelines Working Group, : Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 24 (Suppl 6):vi33–vi38. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010. Lancet. 380:2095–2128. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Dittmer C, Katalinic A, Mundhenke C, Thill M and Fischer D: Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet. 284:169–174. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kopp F and Mendell JT: Functional classification and experimental dissection of long noncoding RNAs. Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bassett AR, Akhtar A, Barlow DP, Bird AP, Brockdorff N, Duboule D, Ephrussi A, Ferguson-Smith AC, Gingeras TR, Haerty W, et al: Considerations when investigating lncRNA function in vivo. Elife. 3:e030582014. View Article : Google Scholar : PubMed/NCBI | |
|
Soudyab M, Iranpour M and Ghafouri-Fard S: The role of long non-coding RNAs in breast cancer. Arch Iran Med. 19:508–517. 2016.PubMed/NCBI | |
|
Geisler S and Coller J: RNA in unexpected places: Long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Grote P and Herrmann BG: Long noncoding RNAs in organogenesis: Making the difference. Trends Genet. 31:329–335. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Nagano T and Fraser P: No-nonsense functions for long noncoding RNAs. Cell. 145:178–181. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Y, Luo M, Brooks M, Clouthier SG and Wicha MS: Biological and clinical significance of cancer stem cell plasticity. Clin Transl Med. 3:322014. View Article : Google Scholar : PubMed/NCBI | |
|
Ørom UA and Shiekhattar R: Long noncoding RNAs usher in a new era in the biology of enhancers. Cell. 154:1190–1193. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wahlestedt C: Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov. 12:433–446. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Hamblin MH and Yin KJ: The long noncoding RNA Malat1: Its physiological and pathophysiological functions. RNA Biol. 14:1705–1714. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB and Chess A: A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics. 8:392007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang B, Arun G, Mao YS, Lazar Z, Hung G, Bhattacharjee G, Xiao X, Booth CJ, Wu J, Zhang C and Spector DL: The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2:111–123. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bernard D, Prasanth KV, Tripathi V, Colasse S, Nakamura T, Xuan Z, Zhang MQ, Sedel F, Jourdren L, Coulpier F, et al: A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J. 29:3082–3093. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wilusz JE, Freier SM and Spector DL: 3′ end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell. 135:919–932. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 584:4575–4580. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Lin C, Liu W, Zhang J, Ohgi KA, Grinstein JD, Dorrestein PC and Rosenfeld MG: ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell. 147:773–788. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al: The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shi X, Sun M, Wu Y, Yao Y, Liu H, Wu G, Yuan D and Song Y: Post-transcriptional regulation of long noncoding RNAs in cancer. Tumour Biol. 36:503–513. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Xu L, Liu Y, Fu S, Tu J, Hu Y and Xiong Q: LncRNA MALAT1 promotes relapse of breast cancer patients with postoperative fever. Am J Transl Res. 10:3186–3197. 2018.PubMed/NCBI | |
|
Zhao M, Wang S, Li Q, Ji Q, Guo P and Liu X: MALAT1: A long non-coding RNA highly associated with human cancers. Oncol Lett. 16:19–26. 2018.PubMed/NCBI | |
|
Tee AE, Ling D, Nelson C, Atmadibrata B, Dinger ME, Xu N, Mizukami T, Liu PY, Liu B, Cheung B, et al: The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget. 5:1793–1804. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Peng R, Luo C, Guo Q, Cao J, Yang Q, Dong K, Wang S, Wang K and Song C: Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population. Gene. 642:241–248. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Q, Zhu C and Jin Y: The oncogenic and tumor suppressive functions of the long noncoding RNA MALAT1: An emerging controversy. Front Genet. 11:932020. View Article : Google Scholar : PubMed/NCBI | |
|
Ni W, Wang X, Sun Y and Gao X: Meta-analysis of the association between MALAT1 rs619586 A>G polymorphism and cancer risk. J Int Med Res. 48:3000605209419692020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang P, Zhou H, Lu K, Lu Y, Wang Y and Feng T: Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer. Onco Targets Ther. 11:291–299. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Zhang Y, Hu K, Qiu J, Hu Y, Zhou M and Zhang S: Elevated long noncoding RNA MALAT-1 expression is predictive of poor prognosis in patients with breast cancer: A meta-analysis. Biosci Rep. 40:BSR202002152020. View Article : Google Scholar : PubMed/NCBI | |
|
Stone JK, Kim JH, Vukadin L, Richard A, Giannini HK, Lim SS, Tan M and Ahn EE: Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells. J Biol Chem. 294:11213–11224. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng L, Zhang Y, Fu Y, Gong H, Guo J, Wu K, Jia Q and Ding X: Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer. Biosci Rep. 39:BSR201812842019. View Article : Google Scholar : PubMed/NCBI | |
|
Fattahi Dolatabadi N, Dehghani A, Shahand E, Yazdanshenas M, Tabatabaeian H, Zamani A, Azadeh M and Ghaedi K: The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer. Hum Cell. 33:1229–1239. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Gomes CP, Nóbrega-Pereira S, Domingues-Silva B, Rebelo K, Alves-Vale C, Marinho SP, Carvalho T, Dias S and Bernardes de Jesus B: An antisense transcript mediates MALAT1 response in human breast cancer. BMC Cancer. 19:7712019. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Y, Sarkissyan M, Ogah O, Kim J and Vadgama JV: Expression of MALAT1 promotes trastuzumab resistance in HER2 overexpressing breast cancers. Cancers (Basel). 12:19182020. View Article : Google Scholar | |
|
Huang XJ, Xia Y, He GF, Zheng LL, Cai YP, Yin Y and Wu Q: MALAT1 promotes angiogenesis of breast cancer. Oncol Rep. 40:2683–2689. 2018.PubMed/NCBI | |
|
Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al: Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 50:1705–1715. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kwok ZH, Roche V, Chew XH, Fadieieva A and Tay Y: A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers. Int J Cancer. 143:668–678. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Eastlack SC, Dong S, Mo YY and Alahari SK: Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer. PLoS One. 13:e01989452018. View Article : Google Scholar : PubMed/NCBI | |
|
Arun G and Spector DL: MALAT1 long non-coding RNA and breast cancer. RNA Biol. 16:860–863. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu SP, Yang JX, Cao DY and Shen K: Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biol Med. 10:138–141. 2013.PubMed/NCBI | |
|
Hosseini ES, Meryet-Figuiere M, Sabzalipoor H, Kashani HH, Nikzad H and Asemi Z: Dysregulated expression of long noncoding RNAs in gynecologic cancers. Mol Cancer. 16:1072017. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Q, Li Q and Xie F: LncRNA-MALAT1 regulates proliferation and apoptosis of ovarian cancer cells by targeting miR-503-5p. Onco Targets Ther. 12:6297–6307. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Khan MA, Chen HC, Zhang D and Fu J: Twist: A molecular target in cancer therapeutics. Tumour Biol. 34:2497–2506. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tania M, Khan MA and Fu J: Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer. Tumour Biol. 35:7335–7342. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Jin Y, Feng SJ, Qiu S, Shao N and Zheng JH: LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway. Eur Rev Med Pharmacol Sci. 21:3176–3184. 2017.PubMed/NCBI | |
|
Guo C and Wang X, Chen LP, Li M, Li M, Hu YH, Ding WH and Wang X: Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 22:3703–3712. 2018.PubMed/NCBI | |
|
Wang ZM, Wan XH, Sang GY, Zhao JD, Zhu QY and Wang DM: miR-15a-5p suppresses endometrial cancer cell growth via Wnt/β-catenin signaling pathway by inhibiting WNT3A. Eur Rev Med Pharmacol Sci. 21:4810–4818. 2017.PubMed/NCBI | |
|
Qiu JJ, Lin XJ, Tang XY, Zheng TT, Lin YY and Hua KQ: Exosomal metastasis-associated lung adenocarcinoma transcript 1 promotes angiogenesis and predicts poor prognosis in epithelial ovarian cancer. Int J Biol Sci. 14:1960–1973. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Xu X, Lv H, Wen Q, Li J, Tan L, Li J and Sheng X: The long noncoding RNA MALAT-1 is highly expressed in ovarian cancer and induces cell growth and migration. PLoS One. 11:e01552502016. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Bai HS, Deng Y and Fan L: High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci. 19:3187–3193. 2015.PubMed/NCBI | |
|
Jiang Y, Li Y, Fang S, Jiang B, Qin C, Xie P, Zhou G and Li G: The role of MALAT1 correlates with HPV in cervical cancer. Oncol Lett. 7:2135–2141. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lu H, He Y, Lin L, Qi Z, Ma L, Li L and Su Y: Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145. Tumour Biol. 37:1683–1691. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Han X, Wang Q, Wang Y, Hu B, Dong X, Zhang H and Wang W: Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer. J Cell Physiol. 234:14170–14180. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang N, Hou MS, Zhan Y, Shen XB and Xue HY: MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 22:7653–7659. 2018.PubMed/NCBI | |
|
Zhao Y, Yang Y, Trovik J, Sun K, Zhou L, Jiang P, Lau TS, Hoivik EA, Salvesen HB, Sun H and Wang H: A novel wnt regulatory axis in endometrioid endometrial cancer. Cancer Res. 74:5103–5117. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chen G, Zhang M, Liang Z, Chen S, Chen F, Zhu J, Zhao M, He J, Hua W and Duan P: Association of polymorphisms in MALAT1 with the risk of endometrial cancer in Southern Chinese women. J Clin Lab Anal. 34:e231462020.PubMed/NCBI | |
|
Cao X, Zhao R, Chen Q, Zhao Y, Zhang B, Zhang Y, Yu J, Han G, Cao W, Li J and Chen X: MALAT1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma. Cancer Biomark. 15:717–723. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Liu R, Li J, Lai Y, Liao Y, Liu R and Qiu W: Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1. Int J Biol Macromol. 81:491–497. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Arun G, Diermeier S, Akerman M, Chang KC, Wilkinson JE, Hearn S, Kim Y, MacLeod AR, Krainer AR, Norton L, et al: Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev. 30:34–51. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Gordon MA, Babbs B, Cochrane DR, Bitler BG and Richer JK: The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing. Mol Carcinog. 58:196–205. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bai L, Wang A, Zhang Y, Xu X and Zhang X: Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway. Exp Cell Res. 366:161–171. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Worku T, Bhattarai D, Ayers D, Wang K, Wang C, Rehman ZU, Talpur HS and Yang L: Long non-coding RNAs: The new horizon of gene regulation in ovarian cancer. Cell Physiol Biochem. 44:948–966. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Pa M, Naizaer G, Seyiti A and Kuerbang G: Long noncoding RNA MALAT1 functions as a sponge of MiR-200c in ovarian cancer. Oncol Res. Sep 11–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI | |
|
Lei R, Xue M, Zhang L and Lin Z: Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP. Onco Targets Ther. 10:35–46. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu P, Wang FQ and Li QR: Correlation study between long non-coding RNA MALAT1 and radiotherapy efficiency on cervical carcinoma and generation of radiotherapy resistant model of cancer. Eur Rev Med Pharmacol Sci. 22:5140–5148. 2018.PubMed/NCBI | |
|
Sun R, Qin C, Jiang B, Fang S, Pan X, Peng L, Liu Z, Li W, Li Y and Li G: Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition. Mol Biosyst. 12:952–962. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xia C, Liang S, He Z, Zhu X, Chen R and Chen J: Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells. Eur J Pharmacol. 830:59–67. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li Q, Zhang C, Chen R, Xiong H, Qiu F, Liu S, Zhang M, Wang F, Wang Y, Zhou X, et al: Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma. Cancer Lett. 383:28–40. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Tian X and Xu G: Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: Systematic review and meta-analysis. BMJ Open. 5:e0086532015. View Article : Google Scholar : PubMed/NCBI | |
|
Du Z, Fei T, Verhaak RG, Su Z, Zhang Y, Brown M, Chen Y and Liu XS: Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol. 20:908–913. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liao H, Chen Q and Xiao J: Reflections on the role of Malat1 in gynecological cancer. Cancer Manag Res. 12:13489–13500. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y and Ma L: New insights into long non-coding RNA MALAT1 in cancer and metastasis. Cancers (Basel). 11:2162019. View Article : Google Scholar | |
|
Amodio N, Raimondi L, Juli G, Stamato MA, Caracciolo D, Tagliaferri P and Tassone P: MALAT1: A druggable long non-coding RNA for targeted anti-cancer approaches. J Hematol Oncol. 11:632018. View Article : Google Scholar : PubMed/NCBI |
